Merck & Co., Inc. (MRK) Financials
Annual revenue, profitability and per-share results for Merck & Co., Inc., as reported in SEC filings.
Revenue • FY2025
$65.01B
▲ 1.3%YoY
Net income • FY2025
$18.25B
▲ 6.6%YoY
Gross margin • FY2025
74.8%
Diluted EPS • FY2025
$7.28
▲ 8.0%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $65.01B | $18.25B | $48.63B | $7.28 | $12.36B | — | +1.3% |
| FY2024 | $64.17B | $17.12B | $48.98B | $6.74 | $18.1B | — | +6.7% |
| FY2023 | $60.12B | $365M | $43.99B | $0.14 | $9.14B | — | +1.4% |
| FY2022 | $59.28B | $14.52B | $41.87B | $5.71 | $14.71B | — | +21.7% |
Figures as reported in Merck & Co., Inc.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Financials for companies related to MRK
Never miss a MRK filing.
Get an email when MRK files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.